Purchase Order 75D30124P20144
Award Date
9/18/24
Potential Completion Date
9/29/25
Potential Value
$80K
Federal Agency
CDC Pittsburgh
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,823.10 firm fixed price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the EZ2 CONNECT MDX SYSTEM FUL-3. This system supports the CDC's biomedical research, public health, and healthcare programs. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. The contract has no set-aside designation and is scheduled for completion by...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $57,348.26 firm fixed-price purchase order contract to Qiagen, LLC, a division of the international provider Qiagen N.V., for QIACUITY equipment and maintenance services. This contract does not have a set-aside designation. Qiagen has a history of providing products and services, such as DNA/RNA extraction kits, next-generation sequencing, and bioinformatics software, to support federal agencies'...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $60,250.00 firm fixed price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V. The contract has an ultimate completion date of September 28, 2024 and was awarded on September 29, 2023. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academics. This contract does not have a set-aside designation. Qiagen has...
The Centers for Disease Control and Prevention (CDC) awarded a $50,613 purchase order contract to Qiagen, LLC to provide products and services in support of the agency's public health programs. As a subsidiary of Qiagen N.V., Qiagen will deliver items from its product catalog to the CDC location in Germantown, Maryland under a firm fixed price arrangement. No additional details were provided on the scope of work. The award draws from the CDC's annual appropriations and advances the agency's...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the acquisition of QIAGEN equipment and reagents. The contract, valued at $134,538.38, does not have a set-aside designation. Qiagen N.V. is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. The company has a history of supporting federal...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $139,797.60 firm-fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V., for the acquisition of laboratory equipment and installation services. The equipment is required for laboratory testing related to the coronavirus response, and the CDC must use the same equipment to standardize testing results. The award was made using simplified acquisition...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $148,000.00 contract is for the delivery of products and services to support the CDC's biomedical research, public health, and healthcare programs. This includes DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, bioinformatics...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $64,817.75 contract provides planned maintenance services for QIAGEN equipment, with a period of performance through March 31, 2024. Qiagen is a major supplier of molecular diagnostics products and services to federal agencies, including the Department of Health and Human Services, Department of Veterans...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $78,929.50 contract is for the provision of laboratory equipment to support the CDC's Division of Digital Public Health and Scientific Information Services (DDPHSIS). The award does not have a set-aside designation. Qiagen is an experienced federal contractor, holding multiple indefinite delivery...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $205,000 purchase order to Qiagen, LLC for their EZ! ADVANCED XL SYSTEM. Qiagen, a subsidiary of Qiagen N.V., will provide its sample preparation and nucleic acid extraction platform to support CDC programs through a one-month period of performance ending in late August 2023. The firm fixed price contract calls for Qiagen to deliver its proprietary system to help CDC process samples...